<bill session="107" type="h" number="1964" updated="2013-07-14T18:57:42-04:00">
  <state datetime="2001-05-23">REFERRED</state>
  <status>
    <introduced datetime="2001-05-23"/>
  </status>
  <introduced datetime="2001-05-23"/>
  <titles>
    <title as="introduced" type="short">Access to Medical Treatment Act of 2001</title>
    <title as="introduced" type="official">To allow patients access to drugs and medical devices recommended and provided by health care practitioners under strict guidelines, and for other purposes.</title>
  </titles>
  <sponsor id="400100"/>
  <cosponsors>
    <cosponsor id="400018" joined="2001-05-23"/>
    <cosponsor id="400054" joined="2001-05-23"/>
    <cosponsor id="400057" joined="2002-03-11"/>
    <cosponsor id="400126" joined="2001-05-23"/>
    <cosponsor id="400129" joined="2001-09-25"/>
    <cosponsor id="400140" joined="2001-05-23"/>
    <cosponsor id="400216" joined="2001-07-26"/>
    <cosponsor id="400237" joined="2001-06-05"/>
    <cosponsor id="400554" joined="2001-09-25"/>
    <cosponsor id="400299" joined="2001-06-05"/>
    <cosponsor id="400311" joined="2001-05-23"/>
    <cosponsor id="400343" joined="2002-03-11"/>
    <cosponsor id="400348" joined="2001-05-23"/>
    <cosponsor id="400357" joined="2001-05-23"/>
    <cosponsor id="400504" joined="2001-11-29"/>
    <cosponsor id="400436" joined="2001-09-25"/>
    <cosponsor id="400438" joined="2001-05-23"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2001-05-23">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2001-06-08">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="107" type="s" number="1378"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Advertising"/>
    <term name="Alternative medicine"/>
    <term name="Civil rights and liberties, minority issues"/>
    <term name="Commerce"/>
    <term name="Conflict of interests"/>
    <term name="Defective products"/>
    <term name="Drug adulteration"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drug interactions"/>
    <term name="Drug therapy"/>
    <term name="Drugs"/>
    <term name="Electronic government information"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Informed consent (Medical law)"/>
    <term name="Internet"/>
    <term name="Medical ethics"/>
    <term name="Medical personnel"/>
    <term name="Medical records"/>
    <term name="Medical supplies"/>
    <term name="Patients' rights"/>
    <term name="Pharmaceutical research"/>
    <term name="Physicians"/>
    <term name="Product safety"/>
    <term name="Right of privacy"/>
    <term name="Science, technology, communications"/>
    <term name="State laws"/>
    <term name="Web sites"/>
  </subjects>
  <amendments/>
  <summary>5/23/2001--Introduced.
Access to Medical Treatment Act of 2001 - Defines: (1) "danger" as an adverse reaction to an unapproved drug or medical device that used as directed causes serious harm which would not otherwise have occurred, or harm more serious than side effects for drugs or medical devices approved by the Federal Food and Drug Administration (FDA) for the same disease or condition; and (2) other terms as used in this Act, including "health care practitioner" and "unapproved drug or medical device."Allows a patient to receive, and the practitioner to provide or administer, any unapproved drug or medical device the patient or their legal representative desires, provided certain conditions are met. Sets forth circumstances under which a health care practitioner may recommend, provide, or administer an unapproved drug or medical device.Requires a practitioner who discovers that an unapproved drug or medical device creates a danger to a patient immediately to cease use and recommendation of such drug or device and provide specified information to its manufacturer and the Director of the Centers for Disease Control and Prevention. Requires the manufacturer that receives such information to: (1) immediately cease sale and distribution of the drug or device; and (2) comply with specified notification and reporting requirements. Sets forth certain investigative and reporting duties that the Director, the Secretary of Health and Human Services, and a practitioner must perform with respect to the dangerousness or effectiveness of unapproved drugs or medical devices.Sets forth a penalty for violations of this Act.</summary>
</bill>
